You Might Like
Bio E's Corbevax, SII's Covovax & antiviral drug Molnupiravir get EUA nodIn a significant boost for India’s fight against Covid-19, the Central Drugs Standard Control Organisation (CDSCO) has granted emergency use authorisation for two more Covid-19 vaccines – Corbevax..IndiaTimes - Published | |
No robust trial data, government rejects SII and Bio E’s proposals on booster jabsIndiaTimes - Published | |
Serum Institute CEO hails WHO's approval of Covovax for emergency useIndiaTimes - Published | |
WHO approves SII's Covovax for emergency useCovavax is the Indian version of the Novavax vaccine brought in India by the Serum Institute of India for children.DNA - Published | |
Covishield production capacity 250-275 million doses a month, Covaxin 50-60 million: MoS HealthThe current vaccine production capacity of Covishield, manufactured by the Serum Institute of India, is approximately 250-275 million doses per month while it is about 50-60 million doses per month for..IndiaTimes - Published | |
SII CEO Adar Poonawalla makes BIG announcement on COVID-19 vaccine for childrenSerum Institute's CEO Adar Poonawalla has said that the vaccine for children will most likely be launched within six months.DNA - Published | |
Government panel rejects SII's plea to administer a third dose of Covishield vaccineSII sought approval to administer the third dose on the basis of adequate stock of Covishield and rising demand for boosters amid emergence of OmicronDNA - Published | |
CDSCO panel seeks local clinical trial data from SII for approval of Covishield as booster doseIndiaTimes - Published | |
Not enough orders, may cut Covishield output by 50%: SIIWith not enough orders for Covishield from the Centre, Serum Institute of India CEO Adar Poonawalla on Tuesday said the company is looking at slashing monthly production of vaccines by at least 50% %...IndiaTimes - Published | |
As Omicron fear intensifies, Serum Institute of India seeks DCGI's approval for Covishield booster shotRecently, Kerala, Rajasthan, Karnataka, and Chhattisgarh have also urged the Centre to decide on allowing booster doses of the COVID-19 vaccine.DNA - Published Also reported by •IndiaTimes | |
How effective is Covishield against Omicron? SII CEO Adar Poonawalla says thisIn India, no cases of the new variant have been detected yet, but the government says it is preparing to deal with it.DNA - Published | |
Serum Institute resumes Covid vaccine exportsIndiaTimes - Published | |
'Vaccine hesitancy biggest threat': SII CEO Adar Poonawalla on COVID-19The government will soon launch a door-to-door vaccination campaign so that no adults are left of vaccination and are covered by next month.DNA - Published | Govt allows SII to export 5 crore doses of Covid-19 vaccine Covovax to IndonesiaIndiaTimes - Published |
Saudi Arabia recognises Serum Institute's Covishield, exempts quarantine for fully vaccinatedCovishield vaccine approval enables fully vaccinated Indian travellers to enter Saudi Arabia without having to undergo institutional quarantine.DNA - Published | Novavax Covid-19 vaccine receives first emergency use authorizationNovavax Inc and partner Serum Institute of India said on Monday they received emergency use authorization for their Covid-19 vaccine in Indonesia, making it the first approval anywhere in the world for..IndiaTimes - Published |
Will have enough doses for booster shots, says PoonawallaAdar Poonawalla, CEO of Serum Institute of India (SII), exuded confidence in meeting the Centre’s goal of immunising all adults by yearend, while announcing that Covid-19 vaccine for children,..IndiaTimes - Published | Serum Institute could export 20-30 million vaccine doses a month to Covax, says Adar PoonawallaIndiaTimes - Published |
India withdraws tit-for-tat Covid advisory for UK travellersThe government has reinstated its earlier guidelines by withdrawing a travel advisory issued on October 1 that made it mandatory for British nationals arriving in India to undergo a mandatory 10-day..IndiaTimes - Published | After tit for tat, UK recognises Serum Institute of India's Covishield, junks ‘discriminatory’ orderFrom October 11, Indians who have been fully vaccinated with WHO-approved Covishield will not be required to undergo the mandatory 10-day quarantine on arrival in the UK, ending a standoff between the..IndiaTimes - Published |
SII gets nod to send Covid vaccines to Nepal, Bangaldesh, Myanmar, bulk to AstraZeneca; Bharat Biotech to IranThe government has permitted Serum Institute of India (SII) to export 10 lakh Covishield doses each to Nepal, Myanmar and Bangladesh, while Bharat Biotech will provide Iran with 10 lakh doses of..IndiaTimes - Published | SII now aims to include kids aged 2 to 6 in vaccination trials in a monthThe Serum Institute of India has expanded Covovax’s paediatric trial in seven to 11 years age bracket across 10 sites in India, including Pune, after ensuring vaccine safety in adolescents. The..IndiaTimes - Published |
Centre got over 65.25 crore Covishield doses, 9.1 crore Covaxin jabs till September 19The Centre has received over 65.25 crore Covishield doses from Serum Institute of India and 9.1 crore doses of Covaxin from Bharat Biotech till September 19, according to official documents. Serum..IndiaTimes - Published | India allows Serum Institute to enrol 7-11 year olds in Covid-19 vaccine trialIndia's drug regulator on Tuesday allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its Covid-19 vaccine trial as the country prepares to protect children from the coronavirus...IndiaTimes - Published |
India warns UK of reciprocal steps over vaccine ‘discrimination’“Covishield is a licensed product of the UK company, manufactured in India of which we have supplied five million doses to the UK,” said Shringla, pointing to the inconsistency in the rules..IndiaTimes - Published | PM Modi, Mamata Banerjee and SII CEO Poonawala in TIME Magazine's '100 most influential people of 2021' listPM Narendra Modi, along with Mamata Banerjee and Adar Poonawala, has secured a place in TIME Magazine's '100 most influential people of 2021' list.DNA - Published Also reported by •IndiaTimes |
SII to supply Inactivated Polio Vaccine to Centre for Universal Immunisation Programme from SeptemberIndiaTimes - Published | Centre places purchase order with Serum Institute for 66 crore Covishield doses to be supplied by Dec: SourcesIndiaTimes - Published |
SII chairman Cyrus Poonawalla against using cocktail of Covid-19 vaccinesIndiaTimes - Published | 136 crore Covishield, Covaxin doses to lead India's vaccination drive during August-DecemberMore than 136 crore Covid-19 vaccine doses are expected to be available till the end of this year, informed the Centre. For the next four months, India's vaccine programme will be accelerated by the..IndiaTimes - Published |
Sputnik V vaccine production in India to go fully on stream in September: RDIFThe production of Sputnik V in India is expected to come fully on stream in September. "Production in India is expected to come fully onstream in September and RDIF expects India to become a major..IndiaTimes - Published | 17 European nations have given nod to Covishield: Serum Institute of IndiaIndiaTimes - Published |
No application received from SII for EU authorisation of Covishield vaccine: EMAPoonawalla last month said that he was 'taking this up at the highest levels with regulators and diplomats' and that he hoped to resolve this matter.DNA - Published Also reported by •IndiaTimes | Serum Institute to start production of Sputnik V vaccine from SeptemberAs part of the technology transfer process, SII has already received cell and vector samples from the Gamaleya Center, which developed the jab.DNA - Published Also reported by •IndiaTimes |
Switzerland, Iceland, 7 EU nations approve Covishield for travel entrySwitzerland, Iceland and seven EU countries have approved Covishield, the AstraZeneca vaccine manufactured by Serum Institute of India, a day after India threatened to put European visitors under..IndiaTimes - Published | 'Submit results on Covavax adult trials first': Govt panel to SII on Covid-19 vaccine trials for childrenIndiaTimes - Published |
Govt panel recommends against allowing SII to conduct trial of Covovax on children aged 2-17 yrsAn expert panel of the country's central drug authority on Wednesday recommended against granting permission to the Serum Institute of India (SII) to conduct the phase 2/3 trial of Covid-19 vaccine..IndiaTimes - Published | Adar Poonawalla says EU green pass Covishield issue has been ‘blown out of proportion’Serum Institute of India CEO Adar Poonawalla played down on Wednesday Covishield not getting approved for the EU green pass, saying, "It is not a controversy at all. It’s been blown out of..IndiaTimes - Published |
'Matter of time': SII's Poonawalla confident of getting EU green pass for CovishieldSerum Institute of India (SII) CEO Adar Poonawalla on Wednesday said that the European approval for its locally manufactured Covishield vaccine is "just a matter of time" and is expected in about a..IndiaTimes - Published | Covishield not a ‘green pass’, Europe-bound Indians fretBENGALURU: The exclusion of Covishield, AstraZeneca’s Covid-19 vaccine manufactured by Pune-based Serum Institute of India, from the European Union’s Covid ‘Green Pass’ has left hundreds of..IndiaTimes - Published |
Serum Institute CEO Adar Poonawalla breaks silence on India's Covishield yet to get European Union 'Green Pass'Indians who are vaccinated with the Covishield may not be eligible for the European Union's 'Green Pass', according to reports.DNA - Published | Serum Institute's COVID-19 vaccine 'Covovax' likely to launch by SeptemberThe new vaccine shall be launched under the brand name of Covovax, which SII is manufacturing in partnership with US pharmaceutical firm Novovax.DNA - Published |
SII, Bharat Biotech seek hike in government price for Covid vaccinesSerum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield and Covaxin shots in private hospitals..IndiaTimes - Published | COVID-19: Serum Institute's Novavax vaccine shows 90% overall efficacyNovavax in collaboration with Indian drug manufacturer Serum Institute of India is manufacturing these vaccines for India and low-income countries.DNA - Published |
Covid-19: Novavax set for India launch with Serum Institute of India as manufacturing partnerThe uncertain path to authorisation in the US for Novavax despite passing the efficacy test with an impressive score of 90.4% might see India emerge as a major destination for the shots with the Serum..IndiaTimes - Published | Covishield produces more antibodies than Covaxin, finds studyCovishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufactured vaccine by Hyderabad-based Bharat Biotech in..IndiaTimes - Published |
COVID-19: DCGI approves Serum Institute to manufacture Sputnik V vaccine in IndiaSII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V.DNA - Published | Serum Institute gets DCGI's nod to manufacture Covid jab Sputnik V in IndiaIndiaTimes - Published |
Serum Institute of India pushes for indemnity after foreign companies’ requestIndiaTimes - Published | US to ease Covid vaccine input supply: Kamala Harris to PM ModiUS Vice-President Kamala Harris on Thursday spoke to PM Narendra Modi to brief him about the Biden administration’s new vaccine policy that will clear supply chains for AstraZeneca and Novavax..IndiaTimes - Published |
